Form 8-K - Current report:
SEC Accession No. 0001753926-25-000467
Filing Date
2025-03-18
Accepted
2025-03-18 17:01:10
Documents
21
Period of Report
2025-03-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K g084733_8k.htm   iXBRL 8-K 73903
2 EXHIBIT 4.2 g084733_ex4-2.htm EX-4.2 86387
3 EXHIBIT 10.1 g084733_ex10-1.htm EX-10.1 56116
4 EXHIBIT 10.4 g084733_ex10-4.htm EX-10.4 131085
5 EXHIBIT 10.5 g084733_ex10-5.htm EX-10.5 59054
6 EXHIBIT 10.6 g084733_ex10-6.htm EX-10.6 57233
7 EXHIBIT 10.7 g084733_ex10-7.htm EX-10.7 234855
8 EXHIBIT 10.8 g084733_ex10-8.htm EX-10.8 132517
9 EXHIBIT 10.9 g084733_ex10-9.htm EX-10.9 111496
  Complete submission text file 0001753926-25-000467.txt   1304494

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE lipo-20250318.xsd EX-101.SCH 3012
11 XBRL LABEL FILE lipo-20250318_lab.xml EX-101.LAB 34240
12 XBRL PRESENTATION FILE lipo-20250318_pre.xml EX-101.PRE 22357
23 EXTRACTED XBRL INSTANCE DOCUMENT g084733_8k_htm.xml XML 3849
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Filer) CIK: 0001347242 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41575 | Film No.: 25749314
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)